Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).

In a new study, researchers investigated the prevalence of cardiovascular disease events (CVE) in people with systemic lupus ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

In a recent study, researchers explored the association between HCQ and the overall risk of CV events in people with SLE.

The PALIZADE clinical study is evaluating zetomipzomib for the treatment of lupus nephritis, its side effects, and how it affects proteins in the urine. The PALIZADE clinical trial is made up of 3 ...

Autoimmune diseases, including systemic lupus erythematosus (SLE), are more common in women than men, and scientists are ...

A recent study found that regularly checking blood levels of hydroxychloroquine (HCQ, known commercially as Plaquenil®) may ...